Fig. 1: Serum 14,15-EET levels are elevated in ApcMin/+ mice prior to intestinal adenoma development. | Oncogenesis

Fig. 1: Serum 14,15-EET levels are elevated in ApcMin/+ mice prior to intestinal adenoma development.

From: 14,15-epoxyeicosatrienoic acid drives intestinal adenoma growth and its value as an early biomarker for intestinal adenoma occurrence

Fig. 1: Serum 14,15-EET levels are elevated in ApcMin/+ mice prior to intestinal adenoma development.

A The schematic diagram for targeted lipidomics assay. B The volcano plot and heatmap illustrating differential lipid metabolites in serum between ApcMin/+ and C57 mice (7 week). C FC of various subtypes of eicosanoid levels in serum between ApcMin/+ and C57 mice (7 week). D The volcano plot and heatmap illustrating differential lipid metabolites in serum between ApcMin/+ and C57 mice (24 week). The results are presented as mean ± SEM (n = 5 per group, P < 0.05, |FC | ≥ 1.2).

Back to article page